Related Experiment Videos
Pyrithione: plasma metabolite in man
Summary
2-Methylsulfonylpyridine (2-MSP) is the final pyrithione metabolite found in plasma across multiple animal species. This study confirms 2-MSP is also the human terminal metabolite, establishing species identity.
Area of Science:
- Toxicology
- Pharmacokinetics
- Metabolism studies
Background:
- Pyrithione compounds are used in various applications.
- Understanding drug metabolism is crucial for safety assessment.
- Previous studies identified 2-Methylsulfonylpyridine (2-MSP) as a terminal metabolite in several animal models.
Purpose of the Study:
- To determine if 2-Methylsulfonylpyridine (2-MSP) is the terminal plasma metabolite in humans.
- To compare the terminal pyrithione metabolite in humans with that of rats, rabbits, dogs, and monkeys.
Main Methods:
- Detection of 2-Methylsulfonylpyridine (2-MSP) in the systemic circulation.
- Analysis of plasma samples from humans occupationally exposed to pyrithione-related chemicals.
Main Results:
- 2-Methylsulfonylpyridine (2-MSP) was identified as the terminal plasma metabolite in humans.
- The identified human metabolite is identical to the one found in rats, rabbits, dogs, and monkeys.
Conclusions:
- The terminal plasma metabolite of pyrithione is conserved across species, including humans.
- This finding has implications for toxicological risk assessment and understanding pyrithione biotransformation.